STICE et al. V. STICE et al. V. STRELCHENKO et al. V. HENSEN et al. - Page 22





                         Giving the phrases their ordinary meaning, Stice's 577 claims and Strelchenko's precritlical                                  
                date claims are directed to mutually exclusive processes of cloning. The Stice 577 claims require                                      
                the insertion of certain somatic cells into an enucleated oocyte, while Strelchenko's precritical date                                 
                claims require insertion of "totipotent cells."                                                                                        
                                                                        C.                                                                             
                         Our analysis, however, can not stop at this point. We must look at the parties' written                                       
                descriptions to see if they have given a different meaning to these phrases. Vitronics, 90 F.3d at                                     
                1582, 39 USPQ2d at 1577.                                                                                                               
                                                                        1                                                                              
                         It is clear from Stice's written description that Stice did not contemplate the use of totipotent                             
                cells as part of the claimed cloning process. As we noted above, totipotent cells are undifferentiated                                 
                cells. What Stice considered significant was the discovery that animals could be cloned from                                           
                differentiated cells. Thus, Stice states:                                                                                              
                                          Prior art methods have used embryonic cell types in cloning                                                  
                                  procedures. This includes work by Campbell et al (Nature, 380:64-68, 1996)                                           
                                  and Stice et al (Biol. Reprod., 54:100-110, 1996). In both of those studies,                                         
                                  embryonic cell lines were derived from embryos of less than 10 days of                                               
                                  gestation. In both studies, the cells were maintained on a feeder layer to                                           
                                  prevent overt differentiation of the donor cell to be used in the cloning                                            
                                  procedure. The present invention uses differentiated cells.                                                          
                                          It was unexpected that cloned embryos with differentiated donor                                              
                                  nuclei could develop to advanced embryonic and fetal stages. The scientific                                          
                                  dogma has been that only embryonic or undifferentiated cell types could                                              
                                  direct this type of development. It was unexpected that a large number of                                            
                                  cloned embryos could be produced from these differentiated cell types. Also,                                         
                                  the fact that new transgenic embryonic cell lines could be readily derived                                           
                                  from transgenic cloned embryos was unexpected.                                                                       
                Stice 577, col. 6,11. 12-30 (emphasis added). Stice father emphasizes the use of differentiated cells:                                 
                                  The present invention relates to cloning procedures in which cell nuclei                                             
                                  derived from differentiated fetal or adult, mammalian cells are transplanted                                         
                                  into enucleated mammalian oocytes of the same species as the donor nuclei.                                           
                                  The nuclei are reprogrammed to direct the development of cloned embryos,                                             
                                  which can then be transferred into recipient females to produce fetuses and                                          
                                  offspring, or used to produce cultured inner cell mass cells (CICM). The                                             


                                                                       -22-                                                                            








Page:  Previous  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  Next 

Last modified: November 3, 2007